Glass House Brands Inc(GLAS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 23 at 7:54 PM ET (Korea 10/24 08:54)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.73 | Insider Own | 13.3% | Shs Outstand | 82.8M | Perf Week | -32.92% |
| Market Cap | 0.17B | Forward P/E | - | EPS next Y | 98.44% | Insider Trans | -0.04% | Shs Float | 67.1M | Perf Month | -70.07% |
| Enterprise Value | 0.31B | PEG | - | EPS next Q | -0.1 | Inst Own | 24.95% | Short Float | 0.56% | Perf Quarter | -78.85% |
| Income | -0.06B | P/S | 1.01 | EPS this Y | 5.19% | Inst Trans | 24.65% | Short Ratio | 0.29 | Perf Half Y | -77.87% |
| Sales | 0.16B | P/B | 2.44 | EPS next 5Y | - | ROA | -15.42% | Short Interest | 0.38M | Perf YTD | -75.82% |
| Book/sh | 0.88 | P/C | 8.93 | EPS past 3/5Y | -2.37% - | ROE | -24.83% | 52W High | -84.64% ($13.93) | Perf Year | -72.28% |
| Cash/sh | 0.24 | P/FCF | - | Sales past 3/5Y | 28.95% 30.4% | ROIC | -22.56% | 52W Low | 28.14% ($1.67) | Perf 3Y | -47.8% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -518.89% | Gross Margin | 21.4% | Volatility(W/M) | 28.4% 15.55% | Perf 5Y | -55.6% |
| Dividend TTM | - | EV/Sales | 1.89 | Sales Y/Y TTM | -2.18% | Oper. Margin | -25.12% | ATR (14) | 0.5 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.7 | EPS Q/Q | -276.47% | Profit Margin | -37.52% | RSI (14) | 7.81 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.33 | Sales Q/Q | -21.46% | SMA20 | -49.31% ($4.22) | Beta | 0.89 | Target Price | $9 |
| Payout | - | Debt/Eq | 0.43 | Earnings | 2026/8/13 | SMA50 | -69.05% ($6.91) | Rel Volume | 1.1 | Prev Close | $2.28 |
| Employees | 426 | LT Debt/Eq | 0.34 | EPS/Sales Surpr. | 8.74% -13.61% | SMA200 | -76.19% ($8.99) | Avg Volume(3M) | 1.31M | Price | $2.14 |
| IPO | 2019/7/18 | Option/Short | Yes/Yes | Trades | 2872 | Volume | 1,440,697 | Change | -6.14% |
🌿 A vertically integrated cannabis company based in California, operating across cultivation, wholesale distribution, and retail dispensaries, along with consumer brands. It operates one of the largest greenhouse cultivation facilities in the United States and is characterized by its proprietary supply chain within the California market.
Over the past 1 year, on the lower side
85% below its 1-year high.
Traded about as much as usual. That is 110% of its average volume.
GLAS has weak earning power
Of every $100 in sales, $25.12 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +5.2% this year.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $101. Peers typically go for $147.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -55.6%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 24.9%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
YOLO AdvisorShares Pure Cannabis ETF 0.04% 
MSOS AdvisorShares Pure US Cannabis ETF <0.01% It ranks #51 of 83 in the industry
Based on market cap of $166M.
ADCT#50 Adc Therapeutics SA $184M PER - GLAS#51 Glass House Brands Inc $166M PER - 
AKBA#52 Akebia Therapeutics Inc $157M PER - 
DERM#53 Journey Medical Corp $142M PER - 
CRDL#54 Cardiol Therapeutics Inc $135M PER - 
FAQ
What kind of company is GLAS?
GLAS belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is the market cap of GLAS?
The market cap of GLAS is approximately $166M, ranking 4,148 within its sector.
What is the 52-week high and low for GLAS?
GLAS has recorded a 52-week high of $13.93 and a low of $1.67.
